Met-Controlled Allosteric Module of Neural Generation as A New Therapeutic Target in Rodent Brain Ischemia
- 4 Downloads
To investigate a Met-controlled allosteric module (AM) of neural generation as a potential therapeutic target for brain ischemia.
We selected Markov clustering algorithm (MCL) to mine functional modules in the related target networks. According to the topological similarity, one functional module was predicted in the modules of baicalin (BA), jasminoidin (JA), cholic acid (CA), compared with I/R model modules. This functional module included three genes: Inppl1, Met and Dapk3 (IMD). By gene ontology enrichment analysis, biological process related to this functional module was obtained. This functional module participated in generation of neurons. Western blotting was applied to present the compound-dependent regulation of IMD. Co-immunoprecipitation was used to reveal the relationship among the three members. We used IF to determine the number of newborn neurons between compound treatment group and ischemia/reperfusion group. The expressions of vascular endothelial growth factor (VEGF) and matrix metalloproteinase 9 (MMP-9) were supposed to show the changing circumstances for neural generation under cerebral ischemia.
Significant reduction in infarction volume and pathological changes were shown in the compound treatment groups compared with the I/R model group (P<0.05). Three nodes in one novel module of IMD were found to exert diverse compound-dependent ischemic-specific excitatory regulatory activities. An anti-ischemic excitatory allosteric module (AME) of generation of neurons (AME-GN) was validated successfully in vivo. Newborn neurons increased in BJC treatment group (P<0.05). The expression of VEGF and MMP-9 decreased in the compound treatment groups compared with the I/R model group (P<0.05).
AME demonstrates effectiveness of our pioneering approach to the discovery of therapeutic target. The novel approach for AM discovery in an effort to identify therapeutic targets holds the promise of accelerating elucidation of underlying pharmacological mechanisms in cerebral ischemia.
Keywordsallosteric module Inppl1-Met-Dapk3 generation of neurons brain ischemia
Unable to display preview. Download preview PDF.
Special thanks to Hang XY and Fang WB for their technical assistances in this study.
- 26.Zhang ZJ, Wang LY, Wang Z, Li PT, Wang YY. Pharmacological evaluation of baicalin and jasminoidin and their combination on focal cerebral ischemia-reperfusion injury. Chin J Chin Mater Med (Chin) 2006;31:907–910.Google Scholar
- 27.Jing ZW, Yan ZL, Zhou CX, Wang LY, Liu J, Wu HL, et al. Comparison of the network structural characteristics of calcium signaling pathway in cerebral ischemia after intervention by different components of Chinese medicine. J Tradit Chin Med 2011;31:251–255.Google Scholar
- 35.Koch A, Mancini A, El BO, Tamura T. The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading. Oncogene 2005;24:3436–3447.CrossRefGoogle Scholar
- 37.Zhou QQ, Liu CE, Wang J, Wang YL, Zhou B. Correlation of vascular endothelial growth factor to permeability of blood-brain barrier and brain edema during high-altitude exposure. Neur Regener Res 2009;10:775–779.Google Scholar
- 38.Wang L, Li Z, Zhang X, Wang S, Zhu C, Miao J, et al. Protective effect of shikonin in experimental ischemic stroke: attenuated TLR4, p-p38MAPK, NF-kappaB, TNF-alpha and MMP-9 expression, up-regulated claudin-5 expression, ameliorated BBB permeability. Neurochem Res 2014;39:97–106.CrossRefGoogle Scholar